CapsoVision, Inc (CV): Cost of Revenue
$6.38M
Year ended 2025-12-31
$6.82M
Trailing 12 months to 2026-06-30
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.38M | +18.6% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $5.38M | n/a | 2026-03-26, From 2024-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| CapsoVision, Inc (CV) | 2025-12-31 | $6.38M | +18.6% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $6.81M | -2.7% |
| Escalon Medical Corp (ESMC) | 2026-06-30 | $7.17M | +9.7% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $10.34M | +361.9% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $3.15M | +2.7% |
| Precision Optics Corporation, Inc. (POCI) | 2026-06-30 | $26.10M | +66.4% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $4.24M | +12.1% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $15.31M | +24.2% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $562.9K | +55.5% |
Compare CV, HYPR, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗